AXSOME THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
AXSOME THERAPEUTICS, INC. (AXSM) reported Increase (Decrease) in Accrued Liabilities of $708.24 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2018-11-09
- AXSOME THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was $434.14K, a 7.00% decline year-over-year.
- AXSOME THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-06-30 was $800.58K.
- AXSOME THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-03-31 was -$526.48K.
- AXSOME THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2017-09-30 was $466.83K, a 41.61% decline year-over-year.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month |
|---|---|---|---|
| 2018-09-30 | $434.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.23M derived: sum of 2 quarters · filed 2018-11-09 | $708.24K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $800.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $274.10K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$526.48K 10-Q · filed 2018-05-08 | ||
| 2017-09-30 | $466.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $208.45K derived: sum of 2 quarters · filed 2018-11-09 | -$76.80K 10-Q · filed 2018-11-09 |
| 2017-06-30 | -$258.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$543.63K 10-Q · filed 2018-08-08 | |
| 2017-03-31 | -$285.25K 10-Q · filed 2018-05-08 | ||
| 2016-09-30 | $799.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $784.64K derived: sum of 2 quarters · filed 2017-11-08 | $2.13M 10-Q · filed 2017-11-08 |
| 2016-06-30 | -$14.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.33M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $1.34M 10-Q · filed 2017-05-09 | ||
| 2015-09-30 | $181.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $330.81K derived: sum of 2 quarters · filed 2016-11-14 | $481.52K 10-Q · filed 2016-11-14 |
| 2015-06-30 | $148.95K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $299.66K 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $150.71K 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |